In individuals with T2DM, dapagliflozin ameliorated insulin sensitivity and caused a shift from glucose to lipid oxidation, which, together with the increased glucagon-to-insulin ratio, are the pathophysiological bases for the enhanced ketone synthesis [202]. This evidence concerns the gene GCG and type 2 diabetes mellitus.